Tchaikapharma High Quality Medicines AD (BUL:THQM)

BUL:THQM Ratios and Metrics

Market cap in millions BGN. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,633	1,761	1,648	1,508	1,360	1,259
Market Cap Growth	-3.82%	6.85%	9.28%	10.88%	8.06%	10.33%
Enterprise Value	1,642	1,773	1,659	1,520	1,372	1,271
Last Close Price	16.12	17.39	16.27	15.39	13.88	12.85

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	280.12	292.92	367.12	443.67	487.62	901.80
PS Ratio	23.57	27.52	31.02	31.10	31.53	29.67
PB Ratio	13.84	15.10	15.06	14.37	13.39	12.74
P/TBV Ratio	14.29	15.59	15.46	14.87	13.91	13.20
P/FCF Ratio	542.79	711.08	1379.40	1579.55	1544.21	2797.58
P/OCF Ratio	441.38	492.41	490.15	526.15	552.80	622.30

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	24.06	27.70	31.22	31.33	31.81	29.95
EV/EBITDA Ratio	164.83	187.88	213.01	223.12	215.21	239.71
EV/EBIT Ratio	255.98	270.09	314.84	379.07	450.56	872.30
EV/FCF Ratio	545.88	715.73	1388.21	1591.28	1557.77	2824.31

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.08	0.10	0.10	0.11	0.12	0.13
Debt / EBITDA Ratio	0.94	1.25	1.43	1.64	1.79	2.36
Debt / FCF Ratio	3.17	4.75	9.31	11.70	13.40	27.75
Net Debt / Equity Ratio	0.08	0.09	0.10	0.11	0.12	0.13
Net Debt / EBITDA Ratio	1.07	1.12	1.41	1.63	1.83	2.35
Net Debt / FCF Ratio	3.14	4.27	9.20	11.64	13.24	27.62
Asset Turnover	0.52	0.47	0.42	0.40	0.36	0.36
Inventory Turnover	0.55	1.07	1.05	2.41	1.03	2.77
Quick Ratio	4.12	3.39	3.83	3.99	3.77	3.63
Current Ratio	5.34	4.43	5.14	5.28	4.84	4.49
Return on Equity (ROE)	5.16%	5.32%	4.19%	3.29%	2.78%	1.43%
Return on Assets (ROA)	3.05%	3.03%	2.62%	2.07%	1.60%	0.78%
Return on Invested Capital (ROIC)	4.62%	4.80%	3.98%	3.07%	2.42%	1.18%
Return on Capital Employed (ROCE)	5.40%	5.50%	4.70%	3.70%	2.90%	1.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	0.36%	0.34%	0.27%	0.22%	0.21%	0.11%
FCF Yield	0.18%	0.14%	0.07%	0.06%	0.07%	0.04%
Buyback Yield / Dilution	1.61%	-	-3.38%	-	-	-37.37%

Data Source: S&P Global Market Intelligence Last updated: Jul 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error